Absorption of tea catechins into rat portal vein

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 2, 1996, Pages 326-329

  Okushio, Kazuo ^a   Matsumoto, Natsuki ^a   Kohri, Toshiyuki ^a   Suzuki, Masayuki ^a   Nanjo, Fumio ^a   Hara, Yukihiko ^a  

^a Mitsui Norin Co Ltd ^*  (Japan)

Author keywords

absorption; portal blood; rat; tea catechin

Indexed keywords

CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; LIVER INJURY; MASS SPECTROMETRY; NONHUMAN; ORAL DRUG ADMINISTRATION; PORTAL VEIN BLOOD FLOW; RAT; TEA;

EID: 0029967854     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.326     Document Type: Article

References (15)

1. a) Yoshizawa S., Horiuchi T., Fujiki H., Yoshida T., Okuda T., Sugimura T., Phytotherapy Res., 1, 44 (1987);
2. b) Hara Y., Tonooka F., Nippon Eiyo Shokuryo Gakkaishi, 43, 345 (1990);
3. c) Nanjo F., Honda M., Okushio K., Matsumoto N., Ishigaki F., Ishigami T., Hara Y., Biol. Pharm. Bull., 16, 1156 (1993);
4. d) Ohsu H., Takeo T., Sugiyama K., Yokota M., Fragrance J., 11, 50 (1990);
5. e) Ohomori Y., Ito M., Kishi M., Mizutani H., Katada T., Konishi H., Biol. Pharm. Bull., 18, 683 (1995).
6. a) Suematsu T., Abe H., "Lipid Peroxides in Biology and Medicine," ed. by Yagi K., Academic Press, New York, 1982, p. 285;
7. b) Glavind J., Hartmann S., Clemmensen J., Jessen K. E., Dam H., Acta Pathol. Microbiol Scand., 30, 1 (1952);
8. c) Meerson F. G., Kagan V. E., Kozlov Yu. P., Belkina L. M., Arkipenko Yu. V., Basic Res. Cardiol, 77, 465 (1982);
9. d) Yoshikawa T., Tanaka H , Kondo M., Biochem Med., 33, 320 (1985);
10. e) Shamberger R. J., Andreone T. L., Willis C. E., J. Natl. Cancer Inst., 53, 1771 (1974).
11. a) Fujita Y., Yamane T , Tanaka M., Kuwata K., Okuzumi J., Takahashi T., Fujiki H., Okuda T., Jpn. J. Cancer Res., 80, 503 (1989);
12. b) Klaunig J. E., Prev. Med., 21, 510 (1992);
13. c) Nishida H., Omori M., Fukutomi Y., Ninomiya M., Nishiwaki S., Suganuma M., Moriwaki H., Muto Y., Jpn. J. Cancer Res., 85, 221 (1994).
14. Okushio K., Matsumoto N., Suzuki M., Nanjo F., Hara Y , Biol. Pharm. Bull., 18, 190 (1995).
15. Matsuzaki T., Hara Y., Nippon Nogeikagaku Kaishi, 61, 803 (1987).